← Browse by Condition
Medical Condition

osteosarcoma metastatic

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT07479732 Phase 1, Phase 2
Recruiting

Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma

Enrollment
56 pts
Location
China
Sponsor
Peking University People's Hos...
View Trial →